NFAT3-regulated extracellular vesicles deliver a combinatorial miRNA signature that suppresses proliferation and invasion in aggressive breast and pancreatic cancer models. This study identifies the underlying molecular programs targeted by the miRNA combination and supports extracellular vesicles as a promising platform for multi-target RNA-based cancer therapy.